Filmmaker Robert Kenner lifts the veil on our nation's food industry, exposing the highly mechanized underbelly that's been hidden from the American consumer with the consent of our government's regulatory agencies, USDA and FDA. Our nation's food supply is now controlled by a handful of corporations that often put profit ahead of consumer health, the livelihood of the American farmer, the safety of workers and our own environment. We have bigger-breasted chickens, the perfect pork chop, insecticide-resistant soybean seeds, even tomatoes that won't go bad, but we also have new strains of e coli--the harmful bacteria that cause illness for an estimated 73,000 Americans annually. We are riddled with widespread obesity, particularly among children, and an epidemic level of diabetes among adults Featuring interviews with such experts as Eric Schlosser (Fast Food Nation), Michael Pollan (The Omnivore's Dilemma) along with forward thinking social entrepreneurs like Stonyfield Farms' Gary Hirschberg and Polyface Farms' Joe Salatin, the film reveals surprising--and often shocking truths--about what we eat, how it's produced, who we have become as a nation and where we are going from here.

The film uncovers the truth about how you really make decisions. Every day you make thousands of decisions, big and small, and behind all them is a powerful battle in your mind, pitting intuition against logic. This conflict affects every aspect of your life - from what you eat to what you believe, and especially to how you spend your money. And it turns out that the intuitive part of your mind is a lot more powerful than you may realise.

Bitcoin is the world's leading virtual currency, but unlike real money, it is not backed by a government or properly regulated. Bitcoin is exchanged and held digitally by users - which is attractive to criminals selling drugs, pornography and arms. But now Bitcoin is moving into the mainstream and being openly marketed as an investment opportunity. The film investigates what Bitcoin is and what it means, going inside a Bitcoin mine in Iceland - where currency is made - and spending time with the Bitcoin millionaires of Silicon Valley.
The programme also hears from others who have been scammed out of their life savings and investors who think the cryptocurrency is an enormous scam and that the writing is on the wall. Around the world, authorities are sounding the alarm that Bitcoin is too risky - is it too late, or too crazy, to try to become a Bitcoin millionaire?

In Los Angeles, a remarkable experiment is underway; the police are trying to predict crime, before it even happens. At the heart of the city of London, one trader believes that he has found the secret of making billions with math. In South Africa, astronomers are attempting to catalogue the entire cosmos. These very different worlds are united by one thing - an extraordinary explosion in data. Meet the people at the forefront of the data revolution, and reveals the possibilities and the promise of the age of big data.

After several rogue traders stories made the headlines these last years, revealing the human factor behind the global economy, neuroscientists have started to scrutinize traders' brain and stress management. What stimulates and motivates them? How can their brain cope with such a high level of stress and competition? This film investigates further into Neuroeconomics, showing how traders are being governed by unconscious psychological and biological processes which can trigger borderline behaviours and have disastrous financial consequences on the financial markets.

Director Chris Bell turns his camera on the abuse of prescription drugs and, ultimately, himself. After witnessing friends and relatives face tragedy as they become addicted to prescription drugs, Bell sets out to explore the goals of pharmaceutical companies and doctors in this ever-growing market, and asks how they are any different from back-alley drug-pushers. His journey leads to experts on the nature of addiction in our culture, as well as to pharmaceutical whistleblowers that testify to the solely dollar-driven aims of pharmaceutical companies.